Target intelligence / Profile preview

Cellular lipids and redox-active macromolecules

Molecular classification
Lipid, Protein, Nucleic acid, Other
01

Overview

Cellular lipids and redox-active macromolecules refers to a diverse group of biological components, primarily polyunsaturated fatty acids (PUFAs) and proteins with sensitive functional groups, that are susceptible to oxidative modification. These molecules are not a single therapeutic target but rather a collective site of action for cytoprotective drugs, antioxidants, and ferroptosis inhibitors (Dixon et al., 2012, Cell). In many disease states, including neurodegeneration and ischemia-reperfusion injury, the uncontrolled oxidation of these macromolecules leads to membrane rupture, protein misfolding, and cell death (Stockwell et al., 2017, Cell). Drugs like amifostine and various lipid-peroxyl radical scavengers interact with this target by neutralizing reactive oxygen species (ROS) before they can cause irreversible damage (Kouvaris et al., 2007, The Oncologist). Consequently, protecting these macromolecules is a key strategy in mitigating radiation damage and preventing ferroptotic cell death in oncological and neurological contexts. This approach focuses on maintaining cellular integrity by preventing the chain reaction of lipid peroxidation and the oxidative inactivation of essential enzymes. While broad, this target class is central to the development of therapies aimed at managing oxidative stress-induced pathologies.

Other names
Cellular membranesPolyunsaturated fatty acidsRedox-sensitive proteinsBiological macromolecules
02

Mechanism of action

Scavenging of reactive oxygen species (ROS) and inhibition of lipid peroxidation to prevent oxidative degradation of cellular components (Halliwell & Gutteridge, 2015, Free Radicals in Biology and Medicine).

03

Biological functions

Redox homeostasisStructural integrityCell signalingEnergy storage
04

Disease associations

CancerNeurodegenerative diseaseIschemia-reperfusion injuryRadiation sickness
05

Safety considerations

Interference with physiological redox signalingPotential for pro-oxidant effects at high dosesLack of specificity
06

Interacting drugs

Amifostine

4 more in the full profile.

07

Biomarkers

Malondialdehyde (MDA)4-Hydroxynonenal (4-HNE)Protein carbonyls8-hydroxy-2'-deoxyguanosine (8-OHdG)

Beyond the preview

Go deeper on Cellular lipids and redox-active macromolecules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cellular lipids and redox-active macromolecules.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call